Cargando…
SAT-275 Bitemporal Hemianopia as a Result of Cabergoline Therapy for Macroprolactinoma
Background: Cabergoline is first-line treatment for prolactin-secreting pituitary macroadenoma (prolactinoma). Side effects such as nausea, valvulopathy and neuropsychiatric symptoms are well recognized complications of its use. A rare complication is vision loss secondary to empty-sella syndrome. C...
Autores principales: | Díaz-Balzac, Carlos A, Williams, Zoe R, Vates, G Edward, Shafiq, Ismat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207920/ http://dx.doi.org/10.1210/jendso/bvaa046.1151 |
Ejemplares similares
-
SAT-LB47 Tension Pneumothorax Following Cabergoline Initiation for Macroprolactinoma
por: Go, Muriel Tania, et al.
Publicado: (2020) -
ODP299 Cabergoline Administration Markedly Improves Cognitive Impairment Associated with Macroprolactinoma
por: Hoang, Thanh, et al.
Publicado: (2022) -
SAT-270 Priapism Secondary to Cabergoline
por: Amir, Maryam, et al.
Publicado: (2020) -
SAT-477 Pituitary Carcinoma Arising from a Macroprolactinoma
por: Gammoh, Emily, et al.
Publicado: (2019) -
SAT-258 Surprising Transformation of a Microprolactinoma to a Macroprolactinoma
por: Athonvarangkul, Diana, et al.
Publicado: (2020)